Skip to main content
. Author manuscript; available in PMC: 2009 Jul 21.
Published in final edited form as: Neuropsychopharmacology. 2007 Feb 21;32(10):2190–2198. doi: 10.1038/sj.npp.1301351

Table 2.

Demographic Characteristics, Hormone Levels, and Symptom Ratings for Women with PMDD and Healthy Controls

Variables PMDD (SD) Healthy (SD)
(n=15) (n=14)
Age (years) 34.5 (6.4) 29.6 (6.5)
Age of education (years) 16.0 (3.1) 16.0 (1.9)
Age at menarche (years) 13.0 (1.3) 12.0 (1.3)
Age at the onset of PMDD (years) 23.0 (7.6) NA
(n=12) (n=12)
Follicular phase
  Estradiol pg/ml 43.3 (13.9) 27.6 (10.8)
  Progesterone ng/ml 0.42 (0.34) 0.39 (0.17)
  DRSP total 33.4 (12.9) 25.0 (1.3)
  Speilberger STAI 29.4 (5.9) 23.0 (4.3)
(n=13) (n=11)
Luteal phase
  Estradiol pg/ml 102.6 (34.5) 99.6 (65.7)
  Progesterone ng/ml 8.5 (3.9) 10.4 (3.6)
  DRSP total 66.1 (19.0) 25.4 (1.4)
  Speilberger STAI 33.2 (5.4) 23.0 (3.4)